“Machine Learning-Driven Pharmacovigilance Models for Drug-Induced Liver Injury (DILI) Risk Prediction and Personalized Therapeutic Dose Optimization in Chronic Liver Disease Patients”. The Science Post, vol. 2, no. 3, Aug. 2026, https://www.thesciencepostjournal.com/index.php/tsp/article/view/254.